Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/23 17:49 | 5/8/23 | KNTE | Health | Drug | Pharmaceutical Preparations | Tananbaum James B. | CA | DT | P | 4,984 | 2.80 | 0 | 1,780 | 21 | 10,192 | I | |||||||||||||||
5/10/23 17:42 | 5/8/23 | KNTE | Health | Drug | Pharmaceutical Preparations | Foresite Capital Management Iv, LLC | CA | T | P | 4,984 | 2.80 | 0 | 1,780 | 21 | 10,192 | I | |||||||||||||||
5/8/23 17:22 | 5/4/23 | KNTE | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | DT | P.m | 4,086 | 2.80 | 0 | 1,461 | 331 | 1,903 | I | |||||||||||||||
5/8/23 17:11 | 5/4/23 | KNTE | Health | Drug | Pharmaceutical Preparations | Gordon Carl L | CA | DT | P.m | 4,086 | 2.80 | 0 | 1,461 | 331 | 1,903 | I | |||||||||||||||
5/2/23 21:38 | 4/28/23 | KNTE | Health | Drug | Pharmaceutical Preparations | Gordon Carl L | CA | DT | P.m | 3,674 | 2.61 | 0 | 1,405 | 1,329 | I | ||||||||||||||||
5/2/23 21:34 | 4/28/23 | KNTE | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | DT | P.m | 3,674 | 2.61 | 0 | 1,405 | 1,329 | I | ||||||||||||||||
3/15/22 17:01 | 3/11/22 | KNTE | Health | Drug | Pharmaceutical Preparations | Williams Richard Thomas | CA | O | Chief Me | P.m | 339 | 8.47 | 0 | 40 | 999% | 42 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |